Stratec SE (SBS.DE) Stock Analysis & Winston Score

Stratec SE is a German company that designs and builds automated analyzer systems used in medical laboratories. These machines help labs run diagnostic tests on blood, urine, and other samples quickly and accurately. Stratec does not sell tests directly to patients — instead, it partners with large diagnostics companies like Roche, Siemens Healthineers, and bioMérieux, which then sell the combined systems under their own brands. Stratec makes most of its money by developing and manufacturing these instruments for its partners under long-term supply agreements, earning revenue from both hardware sales and ongoing instrument placements. The company operates primarily in Europe, with its main facilities in Germany and Switzerland, and generates a significant share of revenue from international markets. Its main competitive advantage is deep engineering expertise in instrument integration, but the low operating margin and negative return on invested capital signal that rising development costs and project delays are currently squeezing profitability — a key risk to watch.